ANKRD22 Downregulation Reprograms Lipid Metabolism to Activate the Notch/Hes1 Pathway, Driving Immunosuppressive Macrophage Polarization in Colorectal Cancer.

Yang B, Hong L, Li S, Li R, Wang R, Yao S, Pan T, Zhong D, Wang C, Zhu Y

Open source

DOI
10.2147/itt.s642879
Published
2026
Container
ImmunoTargets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/itt.s642879,
  title = {ANKRD22 Downregulation Reprograms Lipid Metabolism to Activate the Notch/Hes1 Pathway, Driving Immunosuppressive Macrophage Polarization in Colorectal Cancer.},
  author = {Yang B and Hong L and Li S and Li R and Wang R and Yao S and Pan T and Zhong D and Wang C and Zhu Y},
  year = {2026},
  journal = {ImmunoTargets and therapy},
  doi = {10.2147/itt.s642879},
  url = {https://doi.org/10.2147/itt.s642879}
}

RIS

TY  - JOUR
TI  - ANKRD22 Downregulation Reprograms Lipid Metabolism to Activate the Notch/Hes1 Pathway, Driving Immunosuppressive Macrophage Polarization in Colorectal Cancer.
AU  - Yang B
AU  - Hong L
AU  - Li S
AU  - Li R
AU  - Wang R
AU  - Yao S
AU  - Pan T
AU  - Zhong D
AU  - Wang C
AU  - Zhu Y
PY  - 2026
JO  - ImmunoTargets and therapy
DO  - 10.2147/itt.s642879
UR  - https://doi.org/10.2147/itt.s642879
ER  - 

APA

B, Y., L, H., S, L., R, L., R, W., S, Y., T, P., D, Z., C, W., & Y, Z. (2026). ANKRD22 Downregulation Reprograms Lipid Metabolism to Activate the Notch/Hes1 Pathway, Driving Immunosuppressive Macrophage Polarization in Colorectal Cancer.. ImmunoTargets and therapy. https://doi.org/10.2147/itt.s642879

Source records